Lionel Hebbard
Lionel Hebbard
Associate Professor, Associate Dean, Research, James Cook University
Verified email at - Homepage
Cited by
Cited by
Animal models of nonalcoholic fatty liver disease
L Hebbard, J George
Nature reviews Gastroenterology & hepatology 8 (1), 35-44, 2011
T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model
LW Hebbard, M Garlatti, LJT Young, RD Cardiff, RG Oshima, B Ranscht
Cancer research 68 (5), 1407-1416, 2008
Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells
X Huo, S Han, G Wu, O Latchoumanin, G Zhou, L Hebbard, J George, ...
Molecular cancer 16 (1), 1-10, 2017
Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause?
D van der Poorten, CF Samer, M Ramezani‐Moghadam, S Coulter, ...
Hepatology 57 (6), 2180-2188, 2013
CD44 expression and regulation during mammary gland development and function
L Hebbard, A Steffen, V Zawadzki, C Fieber, N Howells, J Moll, H Ponta, ...
Journal of cell science 113 (14), 2619-2630, 2000
Multifaceted roles of adiponectin in cancer
L Hebbard, B Ranscht
Best practice & research Clinical endocrinology & metabolism 28 (1), 59-69, 2014
Aptamers: A promising chemical antibody for cancer therapy
G Zhou, G Wilson, L Hebbard, W Duan, C Liddle, J George, L Qiao
Oncotarget 7 (12), 13446, 2016
Increased expression of H/T-cadherin in tumor-penetrating blood vessels
L Wyder, A Vitaliti, H Schneider, LW Hebbard, DR Moritz, M Wittmer, ...
Cancer research 60 (17), 4682-4688, 2000
Maternal embryonic leucine zipper kinase is upregulated and required in mammary tumor-initiating cells in vivo
LW Hebbard, J Maurer, A Miller, J Lesperance, J Hassell, RG Oshima, ...
Cancer research 70 (21), 8863-8873, 2010
Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer
MS Denzel, LW Hebbard, G Shostak, L Shapiro, RD Cardiff, B Ranscht
Clinical Cancer Research 15 (10), 3256-3264, 2009
Embelin Reduces Colitis-Associated Tumorigenesis through Limiting IL-6/STAT3 SignalingEmbelin Reduces Colitis-Associated Tumorigenesis
Y Dai, H Jiao, G Teng, W Wang, R Zhang, Y Wang, L Hebbard, J George, ...
Molecular cancer therapeutics 13 (5), 1206-1216, 2014
The role of fructose in metabolism and cancer
B Charrez, L Qiao, L Hebbard
Hormone molecular biology and clinical investigation 22 (2), 79-89, 2015
Angiogenic acceleration of Neu induced mammary tumor progression and metastasis
RG Oshima, J Lesperance, V Munoz, L Hebbard, B Ranscht, N Sharan, ...
Cancer research 64 (1), 169-179, 2004
Non-viral causes of liver cancer: does obesity led inflammation play a role?
B Alzahrani, TJ Iseli, LW Hebbard
Cancer letters 345 (2), 223-229, 2014
Role of adiponectin and its receptors in cancer
S Obeid, L Hebbard
Cancer biology & medicine 9 (4), 213, 2012
The role of micronutrients in the infection and subsequent response to hepatitis C virus
S Gupta, SA Read, NA Shackel, L Hebbard, J George, G Ahlenstiel
Cells 8 (6), 603, 2019
Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play
B Charrez, L Qiao, L Hebbard
World journal of gastroenterology 22 (8), 2494, 2016
Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancers
G Zhou, O Latchoumanin, L Hebbard, W Duan, C Liddle, J George, L Qiao
Advanced drug delivery reviews 134, 107-121, 2018
Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development
CM Jiang, CW Pu, YH Hou, Z Chen, M Alanazy, L Hebbard
World Journal of Gastroenterology: WJG 20 (44), 16464, 2014
Experimental nonalcoholic steatohepatitis compromises ureagenesis, an essential hepatic metabolic function
KL Thomsen, H Grønbæk, E Glavind, L Hebbard, N Jessen, A Clouston, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 307 (3 …, 2014
The system can't perform the operation now. Try again later.
Articles 1–20